NMT Set To Study Next-Generation BioStar Tissue-Based PFO Closure Device
This article was originally published in The Gray Sheet
Executive Summary
NMT Medical plans to begin human clinical studies of its next-generation, bio-resorbable patent foramen ovale (PFO) closure device,BioStar, in the second quarter of this year